Stock listing

NASDAQ:ONCT Oncternal Therapeutics Inc Stock

Follow Oncternal Therapeutics Inc into a list and get an email when it puts out news.

Delisted NASDAQ:ONCT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ONCT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Oncternal Therapeutics Inc on 6ix

Calls
11 calls with a replay · 11 with a transcript · latest Aug 8, 2024

Events

CallWhenStatus
Oncternal Therapeutics (ONCT) Q2 2024 Earnings CallThu, Aug 08, 2024 · 5:00 PM ETReplay
Oncternal Therapeutics (ONCT) Q1 2024 Earnings CallThu, May 09, 2024 · 5:00 PM ETReplay
Oncternal Therapeutics (ONCT) Q4 2023 Earnings CallThu, Mar 07, 2024 · 5:00 PM ETReplay
Oncternal Therapeutics (ONCT) Q3 2023 Earnings CallThu, Nov 09, 2023 · 5:00 PM ETReplay
Oncternal Therapeutics (ONCT) Q2 2023 Earnings CallThu, Aug 10, 2023 · 5:00 PM ETReplay
Oncternal Therapeutics (ONCT) Q1 2023 Earnings CallThu, May 04, 2023 · 5:00 PM ETReplay
Oncternal Therapeutics (ONCT) Q3 2022 Earnings CallThu, Nov 03, 2022 · 5:00 PM ETReplay
Oncternal Therapeutics (ONCT) Q2 2022 Earnings CallTue, Aug 09, 2022 · 5:00 PM ETReplay
Oncternal Therapeutics (ONCT) Q1 2022 Earnings CallThu, May 05, 2022 · 5:00 PM ETReplay
Oncternal Therapeutics (ONCT) Q4 2021 Earnings CallThu, Mar 10, 2022 · 5:00 PM ETReplay
All 11 calls
CallWhenStatus
Oncternal Therapeutics (ONCT) Q3 2021 Earnings CallThu, Nov 04, 2021 · 5:00 PM ETReplay

Open Events

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rosemary Mazanet
Other companies: Kairos Pharma, Ltd. (Director · Sep 16, 2024 – Sep 16, 2024 · Past); Actinium Pharmaceuticals, Inc. (Delaware) (Director · Dec 28, 2012 – May 15, 2013 · Past); SELLAS Life Sciences Group, Inc. (Chief Medical Officer · Feb 1, 2012 – Jan 29, 2013 · Past); Abeona Therapeutics Inc. (Director · Jan 4, 2007 – Jan 4, 2007 · Past); Aksys Ltd (Director · Aug 9, 2006 – Oct 24, 2006 · Past)
Director · Jan 1, 2006 – Jun 20, 2024 · Past
David Hale
Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Histogen Inc (Director · Jul 24, 2013 – Jun 27, 2019 · Past); Somaxon Pharmaceuticals Inc (Director · Apr 2, 2012 – Dec 31, 2012 · Past); Santarus Inc (Director · Mar 21, 2012 – Jan 2, 2014 · Past)
Director · Jun 7, 2019 – Jun 20, 2024 · Past
James Breitmeyer
Other companies: Vaxart, Inc. (Director · Since at least Apr 23, 2026); Otonomy Inc (Director · Jun 19, 2018 – Jun 21, 2022 · Past); Zogenix Inc (Director · Jul 13, 2016 – Mar 7, 2022 · Past)
Chief Executive Officer, Director · Jun 7, 2019 – Feb 14, 2024 · Past
Chase C Leavitt
Other companies: Mobia Medical, Inc. (SEE REMARKS · Since at least May 7, 2026); Lineage Cell Therapeutics, Inc. (General Counsel/Secretary · May 20, 2019 – Mar 15, 2021 · Past)
General Counsel/Secretary · May 25, 2021 – Feb 14, 2024 · Past
Daniel L Kisner
Other companies: Dynavax Technologies Corporation (Director · Since at least May 23, 2024); Zynerba Pharmaceuticals Inc (Director · Oct 10, 2023 – Oct 10, 2023 · Past)
Director · Jun 20, 2024 – Jun 20, 2024 · Past
Robert Wills
Other companies: Alpha Cognition Inc. (Chairman · Since at least Apr 7, 2025); Milestone Pharmaceuticals Inc. (Director · Since at least Oct 1, 2020)
Director · Mar 2, 2015 – Jun 20, 2024 · Past
William R Larue
Other companies: Histogen Inc (Director · Feb 6, 2017 – Jun 27, 2019 · Past); Cadence Pharmaceuticals Inc (SVP, CFO, Treas, Asst Sec · Oct 24, 2006 – Mar 19, 2014 · Past)
Director · Jun 7, 2019 – Jun 20, 2024 · Past
Charles Theuer
Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020)
Director · Jun 7, 2019 – Jun 20, 2024 · Past
Diane C. Young
Other companies: Celldex Therapeutics, Inc. (Senior Vice President and Chief Medical Officer · Since at least Jul 8, 2019)
VP, Chief Medical Officer · Jul 13, 2015 – Jul 13, 2018 · Past
Frank J Hsu
Other companies: Apexigen Inc. (Chief Medical Officer · Jul 29, 2022 – Aug 23, 2023 · Past)
Chief Medical Officer · Aug 26, 2019 – Mar 17, 2020 · Past
All 22 people
PersonSeat
Mitchell S. Steiner
Other companies: Veru Inc. (Chairman, President, and Chief Executive Officer · Since at least Oct 31, 2016)
Chief Executive Officer, Director · Feb 24, 2006 – Jan 29, 2014 · Past
Richard G Vincent
Other companies: Forte Biosciences, Inc. (Director · Since at least Sep 17, 2024)
Chief Financial Officer · Jun 7, 2019 – Feb 14, 2024 · Past
Andrew M ClarksonDirector · Jan 1, 2006 – Jun 30, 2008 · Past
Gunnar F KaufmannChief Scientific Officer · Jul 28, 2022 – Jun 12, 2023 · Past
Henry Patton DoggrellVP, Chief Legal Officer · Oct 1, 2013 – Jun 20, 2018 · Past
Jeffrey G HesselbergVice President, Regulatory · May 15, 2007 – Jul 30, 2008 · Past
Jinzhu PhD ChenDirector · May 25, 2021 – Jun 16, 2022 · Past
Kenneth S RobinsonDirector · Sep 30, 2008 – Oct 1, 2018 · Past
Mark Edward MostellerVice President, CFO · May 12, 2006 – Jul 8, 2013 · Past
Rajesh KrishnanCTO/CSO · Jul 28, 2022 – Feb 14, 2024 · Past
Salim YazjiChief Medical Officer · Oct 2, 2023 – Feb 14, 2024 · Past
Xin NakanishiDirector · Jun 7, 2019 – Jun 28, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Oncternal Therapeutics Inc.